Cargando…

Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk

Genome-wide association study (GWAS) evidence has identified the metabotropic glutamate receptor 3 (GRM3) gene as a potential harbor for schizophrenia risk variants. However, previous meta-analyses have refuted the association between GRM3 single-nucleotide polymorphisms (SNPs) and schizophrenia ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saini, S M, Mancuso, S G, Mostaid, Md S, Liu, C, Pantelis, C, Everall, I P, Bousman, C A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611739/ https://www.ncbi.nlm.nih.gov/pubmed/28786982 http://dx.doi.org/10.1038/tp.2017.172

Ejemplares similares

Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia
por: Mostaid, M S, et al.
Publicado: (2017)

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Interrogating the Evolutionary Paradox of Schizophrenia: A Novel Framework and Evidence Supporting Recent Negative Selection of Schizophrenia Risk Alleles
por: Liu, Chenxing, et al.
Publicado: (2019)

Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia
por: Bousman, Chad A., et al.
Publicado: (2019)

F192. SYSTEMATIC META-ANALYSIS IDENTIFIES FIVE NOVEL ASSOCIATION LOCI FOR SCHIZOPHRENIA
por: Liu, Chenxing, et al.
Publicado: (2018)

No evidence for association between polymorphisms in GRM3 and schizophrenia
por: Norton, Nadine, et al.
Publicado: (2005)

Deleterious GRM1 Mutations in Schizophrenia
por: Ayoub, Mohammed Akli, et al.
Publicado: (2012)

Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations
por: Liu, C, et al.
Publicado: (2017)

The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies
por: Liu, Chenxing, et al.
Publicado: (2019)

Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia
por: Liang, Wei, et al.
Publicado: (2020)

Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia
por: Mohamed Saini, Suriati, et al.
Publicado: (2023)

Perturbed iron biology in the prefrontal cortex of people with schizophrenia
por: Lotan, Amit, et al.
Publicado: (2023)

S187. EXPLORING NEURODEVELOPMENTAL AND FAMILIAL ORIGINS OF NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA
por: Cooper, Rebecca, et al.
Publicado: (2020)

Schizophrenia genetics in the genome-wide era: a review of Japanese studies
por: Kanazawa, Tetsufumi, et al.
Publicado: (2017)

The role of group II metabotropic glutamate receptors in cognition and anxiety: Comparative studies in GRM2(−/−), GRM3(−/−) and GRM2/3(−/−) knockout mice
por: De Filippis, Bianca, et al.
Publicado: (2015)

T157. FRONTOSTRIATAL CONNECTIVITY IN TREATMENT-RESISTANT SCHIZOPHRENIA: RELATIONSHIP TO POSITIVE SYMPTOMS AND COGNITIVE FLEXIBILITY
por: Cropley, Vanessa, et al.
Publicado: (2018)

Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice
por: Lyon, Louisa, et al.
Publicado: (2008)

O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS
por: Cropley, Vanessa, et al.
Publicado: (2018)

No Association Between GRM3 and Japanese Methamphetamine-Induced Psychosis
por: Tsunoka, Tomoko, et al.
Publicado: (2011)

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis
por: Chana, Gursharan, et al.
Publicado: (2013)

Beyond the GWAS in schizophrenia
por: Malhotra, Anil K
Publicado: (2011)

A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression
por: Warburton, Alix, et al.
Publicado: (2016)

circ-Grm1 promotes pulmonary artery smooth muscle cell proliferation and migration via suppression of GRM1 expression by FUS
por: Sun, Shijing, et al.
Publicado: (2021)

Sequence variations of GRM6 in patients with high myopia
por: Xu, Xiaoyu, et al.
Publicado: (2009)

Correlation between variants of the CREB1 and GRM7 genes and risk of depression
por: Wang, Li, et al.
Publicado: (2023)

Analysis of GWAS-Derived Schizophrenia Genes for Links to Ischemia-Hypoxia Response of the Brain
por: Schmidt-Kastner, Rainald, et al.
Publicado: (2020)

Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma
por: Alb, Miriam, et al.
Publicado: (2012)

The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder
por: O’Brien, Niamh L., et al.
Publicado: (2014)

Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy
por: Marafi, Dana, et al.
Publicado: (2020)

The role of rs2237781 within GRM8 in eating behavior
por: Gast, Marie-Therese, et al.
Publicado: (2013)

GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
por: Xia, Wenlong, et al.
Publicado: (2015)

Genome-Wide Supported Risk Variants in MIR137, CACNA1C, CSMD1, DRD2, and GRM3 Contribute to Schizophrenia Susceptibility in Pakistani Population
por: Fatima, Ambrin, et al.
Publicado: (2017)

F158. FUNCTIONAL CONNECTIVITY DIVERSITY OF THE INSULA CORTEX IN SCHIZOPHRENIA: SUBREGIONS OR CONTINUA?
por: Tian, Ye, et al.
Publicado: (2018)

Loss-of-Function Models of the Metabotropic Glutamate Receptor Genes Grm8a and Grm8b Display Distinct Behavioral Phenotypes in Zebrafish Larvae (Danio rerio)
por: Lüffe, Teresa M., et al.
Publicado: (2022)

Metabotropic Glutamate Receptor 1 (Grm1) Is An Oncogene In Epithelial Cells
por: Martino, Jeffrey J, et al.
Publicado: (2012)

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
por: Watson, Lauren M., et al.
Publicado: (2017)

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
por: Watson, Lauren M., et al.
Publicado: (2017)

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
por: Watson, Lauren M., et al.
Publicado: (2017)

Encapsulation mechanisms and structural studies of GRM2 bacterial microcompartment particles
por: Kalnins, Gints, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ael6rr8qjdijkdd8dg6u3bcj1q